Management of women with type 2B von Willebrand disease during pregnancy and postpartum: guidance from ISTH SSC subcommittees on von Willebrand factor and women’s health issues in thrombosis and hemostasis
Journal of Thrombosis and Haemostasis · 2026-09 · 24 (9) · 3392-3404
DOI: 10.1016/j.jtha.2026.05.032 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-09. Verfasst von Predrag Miljic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Haematology, University Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia. Hauptthemen laut MEDLINE: von Willebrand Disease, Type 2, von Willebrand Factor, Hemostasis, Pregnancy Complications, Hematologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Type 2B von Willebrand disease (VWD) is a rare qualitative variant, accounting for ∼5% of all VWD cases. It is characterized by increased affinity of abnormal von Willebrand factor (VWF) for the platelet glycoprotein Ibα receptor, resulting in enhanced clearance of both high-molecular-weight VWF multimers and platelets from circulation. The management of women with type 2B VWD during pregnancy and the postpartum period poses unique challenges due to complex hemostatic abnormalities, a high risk of bleeding complications, and a lack of evidence-based guidelines. A recent systematic review, international registry analysis, and global physician survey highlighted several unmet clinical needs in this population, including gaps in early diagnosis, prenatal counseling, pregnancy monitoring, and peripartum management. In response, the International Society on Thrombosis and Haemostasis Scientific Subcommittees on VWF and on Women's Health Issues in Thrombosis and Haemostasis collaborated to develop consensus-based guidance for the management of type 2B VWD in pregnancy and postpartum. Using the real-time Delphi methodology, 14 international experts reviewed 26 initial statements on diagnosis, monitoring, and treatment. After 2 rounds of anonymous voting and revisions based on participants' feedback, consensus was achieved on 25 statements. These consensus statements, grounded in the best available evidence and expert opinion, aim to standardize care, guide management, and improve clinical outcomes for women with type 2B VWD during pregnancy and postpartum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic of Haematology, University Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
- Faculty of Medicine, Ottawa University, Ottawa, ON, Canada.
- Hematological Research Institute, National Academy of Medicine, Buenos Aires, Argentina.
- Katharine Dormandy Haemophila and Thrombosis Unit, Department of Obstetrics and Gynaecology, The Royal Free Hospital, Institute for Women's Health, UCL, London, UK.
- Division of Hematology, St. James' Hospital, Dublin, Ireland.
- Institute for Health Research, University of Notre Dame Australia, Perth, Australia; Clinical Research Unit, Perth Blood Institute, Perth, Australia; Hollywood Hospital Haemophilia Centre, Haematology Academic Unit, Per…
Zitieren
APA
Miljic, P., Noureldin, A., Sanchez-Luceros, A., Abdul-Kadir, R., Lavin, M., Baker, R. I., Sidonio, R., James, P. D., & Othman, M. (2026). Management of women with type 2B von Willebrand disease during pregnancy and postpartum: guidance from ISTH SSC subcommittees on von Willebrand factor and women’s health issues in thrombosis and hemostasis. Journal of Thrombosis and Haemostasis, 24(9), 3392-3404. https://doi.org/10.1016/j.jtha.2026.05.032
Vancouver
Miljic P, Noureldin A, Sanchez-Luceros A, Abdul-Kadir R, Lavin M, Baker RI, et al. Management of women with type 2B von Willebrand disease during pregnancy and postpartum: guidance from ISTH SSC subcommittees on von Willebrand factor and women’s health issues in thrombosis and hemostasis. Journal of Thrombosis and Haemostasis. 2026;24(9):3392-3404. doi:10.1016/j.jtha.2026.05.032
BibTeX
@article{Miljic2026,
author = {Miljic, Predrag and Noureldin, Abdelrahman and Sanchez-Luceros, Analia and Abdul-Kadir, Rezan and Lavin, Michelle and Baker, Ross I and Sidonio, Robert and James, Paula D and Othman, Maha},
title = {Management of women with type 2B von Willebrand disease during pregnancy and postpartum: guidance from ISTH SSC subcommittees on von Willebrand factor and women’s health issues in thrombosis and hemostasis},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
volume = {24},
number = {9},
pages = {3392--3404},
doi = {10.1016/j.jtha.2026.05.032}
}
EUVIMED